UNSPSC 85407007: Diagnosis of chondroectodermal dysplasia

This classification denotes the group of activities that yields a diagnosis of Chondroectodermal dysplasia. Chondroectodermal dysplasia is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code Q77. 6

UNSPSC 85407007 Diagnosis of chondroectodermal dysplasia, a Commodity code, shows minimal alignment between its nominal scope—a rare genetic disorder diagnosis—and the state and local opportunities actually posted under it. The three recent solicitations span diagnostic imaging systems, ultrasound equipment, and phlebotomy services, none of which directly address chondroectodermal dysplasia diagnosis. State and local health systems and public safety agencies are using this code tag for general clinical diagnostic and specimen-collection capabilities rather than for a condition-specific diagnostic pathway. The issuing bodies include a county-operated medical center (San Mateo Medical Center), a county health system (Collier County), and a municipal police department (Albuquerque Police Department).

Activity appears concentrated in California and Florida, with one solicitation in New Mexico. San Mateo Medical Center posted an RFP on July 9, 2026 due August 7, 2026 for enterprise-grade Picture Archiving and Communication System (PACS) implementation supporting radiology, cardiology, dental imaging, and EPIC Electronic Health Record integration, with a five-year agreement term and local preference available under San Mateo County Ordinance. Collier County, Florida issued a Notice of Intent to Single Source EchoNous, Inc. for KOSMOS ultrasound platform and TORSO-ONE USB probe equipment with a five-year warranty, posted April 1, 2026. The Albuquerque Police Department issued an RFB on January 26, 2026 due February 25, 2026 for on-call phlebotomy technician services across Bernalillo County, anticipating 300 annual calls with a three-year initial term renewable for two additional one-year periods. The code's application here reflects how procurement offices tag diagnostic and specimen-collection services broadly rather than condition-specific clinical pathways.